MidDiagnosed 2026-09-27 21:09:45 KSTMMIRMAI Stock Diagnostic ReportMirum to present phase 3 hepatitis delta study results MondayMirum plans to announce Phase 3 study results for its hepatitis B delta virus treatment on Monday, but the stock's direction remains uncertain as the results have not yet been disclosed.View Source Article ↗ AI CATALYST SCORE50 / 100Score computed by Sentinel V12REFERENCE PRICENot measuredReference entry price at analysis time 👍 0🔥 0🤔 0🔗 0𝕏f🔗📤